<DOC>
	<DOCNO>NCT00553566</DOCNO>
	<brief_summary>RATIONALE : Learning long-term effect dietary , lifestyle , environmental factor risk cancer progression recurrence may help study bladder cancer future . PURPOSE : This clinical trial study dietary , lifestyle , environmental factor affect patient early-stage bladder cancer .</brief_summary>
	<brief_title>Effect Dietary , Lifestyle , Environmental Factors Patients With Early-Stage Bladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To examine common potentially modifiable dietary , lifestyle , environmental exposure affect risk recurrence progression bladder cancer . OUTLINE : This multicenter study . Detailed information collect patient ' lifestyle exposure risk factor associate bladder cancer use semi-structured questionnaire . A baseline questionnaire administer time diagnosis collect information socio-demographics , environmental exposure , medical history , diet , health-related quality life , social support . Further questionnaire administer regular follow-up visit capture information relate change exposure . A postal questionnaire use collect historical information may require patient check record consult family friend . Patients also ask keep 1-week food , fluid , micturition diary . Patients continue complete questionnaire 3 month annually 5 year . Peer Reviewed Funded Endorsed Cancer Research UK .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Enrolled parent protocol CRUKBCPP200501 Bladder lesion cystoscopic characteristic compatible urothelial cancer transitional cell carcinoma Histologically proven urothelial cancer meet one follow criterion : Stage Ta ( WHO grade 2/3 , grade 1 tumor either multifocal &gt; 3 cm size ) Stage T1 ( grade ) Stage Tis Exclusion criterion : Previous diagnosis cancer urethra , bladder , ureter , renal pelvis within 10 year prior current diagnosis PATIENT CHARACTERISTICS : Inclusion criterion : Fit cystoscopy surgical biopsy/resection Exclusion criterion : HIV infection Any condition , opinion local investigator , might interfere safety patient evaluation study objective PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>stage 0 bladder cancer</keyword>
	<keyword>stage I bladder cancer</keyword>
	<keyword>transitional cell carcinoma bladder</keyword>
</DOC>